Skip to content
DataLookout
Menu

NCT05896501

Role of FFR in ACS Patients: Pressure ACS Registry

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 7 words Show 6 more changesShow less
    • Trial completed
    • Study completion date changed from estimate of Dec 31, 2026 to Dec 31, 2025
    • Enrollment target: 500 to 501
    • Secondary endpoints revised (4)
    • Study description expanded, about 7 words
    • Site details revised at 5 of 5 sites
  2. Notable Primary completion date: Jan 31, 2025 to Dec 31, 2025
    • Study completion date: Jun 30, 2025 to Dec 31, 2026
    v3
  3. Notable Primary endpoint revised
    • Secondary endpoints revised (4)
    • Study title expanded, about 7 words
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Rate of Major adverse cardiac events
Timeframe: 24 months

Secondary (4)

Rate of Target vessel failure
Rate of Death
Rate of myocardial infarction
Rate of Repeat revascularization

Arms and interventions

Devices: Fractional Flow Reserve

Sites

5 sites in 1 country